MediciNova Statistics
Total Valuation
MediciNova has a market cap or net worth of $99.22 million. The enterprise value is $53.56 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MediciNova has 49.05 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 49.05M |
| Shares Outstanding | 49.05M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.98% |
| Owned by Institutions (%) | 10.07% |
| Float | 42.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.74 |
| P/TBV Ratio | 2.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.66, with a Debt / Equity ratio of 0.00.
| Current Ratio | 16.66 |
| Quick Ratio | 16.28 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -17.19% and return on invested capital (ROIC) is -12.42%.
| Return on Equity (ROE) | -17.19% |
| Return on Assets (ROA) | -11.86% |
| Return on Capital (ROIC) | -12.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$791,845 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MediciNova has paid $3,047 in taxes.
| Income Tax | 3,047 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.80% in the last 52 weeks. The beta is 0.77, so MediciNova's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -1.80% |
| 50-Day Moving Average | 1.83 |
| 200-Day Moving Average | 1.50 |
| Relative Strength Index (RSI) | 58.70 |
| Average Volume (20 Days) | 148,783 |
Short Selling Information
The latest short interest is 182,203, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 182,203 |
| Short Previous Month | 198,205 |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.43% |
| Short Ratio (days to cover) | 11.20 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.98M |
| Pretax Income | -8.16M |
| Net Income | -10.29M |
| EBITDA | -11.96M |
| EBIT | -11.98M |
| Earnings Per Share (EPS) | -$0.21 |
Full Income StatementBalance Sheet
The company has $42.28 million in cash and $201,976 in debt, giving a net cash position of $42.08 million or $0.86 per share.
| Cash & Cash Equivalents | 42.28M |
| Total Debt | 201,976 |
| Net Cash | 42.08M |
| Net Cash Per Share | $0.86 |
| Equity (Book Value) | 55.07M |
| Book Value Per Share | 1.12 |
| Working Capital | 40.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.21 million and capital expenditures -$875, giving a free cash flow of -$9.21 million.
| Operating Cash Flow | -9.21M |
| Capital Expenditures | -875 |
| Free Cash Flow | -9.21M |
| FCF Per Share | -$0.19 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -855.34% |